Clinical Trial Update: A Prospective Multicenter Diagnostic Biomarker Study to Discriminate Borderline from Stage I Invasive Ovarian Cancer

View source ↗

Summary

This is a prospective multicenter diagnostic biomarker study designed to discriminate borderline ovarian tumors from stage I invasive ovarian cancer. The trial …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Borderline Ovarian Tumor
• Ovarian Cancer

Snippet

Sponsor: KU Leuven | Conditions: Stage I Ovarian Cancer, Borderline Ovarian Tumors | Status: ACTIVE_NOT_RECRUITING